Cryptosporidium parvum Pyruvate Kinase Inhibitors With in vivo Anti-cryptosporidial Efficacy

Cryptosporidium parvum is a highly prevalent protozoan parasite that causes a diarrheal disease in humans and animals worldwide. Thus far, the moderately effective nitazoxanide is the only drug approved by the United States Food and Drug Administration for treating cryptosporidiosis in immunocompete...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Shahbaz M., Zhang, Xuejin, Witola, William H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761912/
https://www.ncbi.nlm.nih.gov/pubmed/35046922
http://dx.doi.org/10.3389/fmicb.2021.800293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761912/
https://www.ncbi.nlm.nih.gov/pubmed/35046922
http://dx.doi.org/10.3389/fmicb.2021.800293

Ejemplares similares